EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiopulmonary Complications after Pulmonary Embolism in COVID-19

Carla Suarez-Castillejo, Néstor Calvo, Luminita Preda, Rocío Córdova Díaz, Nuria Toledo-Pons, Joaquín Martínez, Jaume Pons, Miquel Vives-Borràs, Pere Pericàs, Luisa Ramón, Amanda Iglesias, Laura Cànaves-Gómez und 6 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carla Suarez-Castillejo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Neumología, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Embolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IdISBa COVID-19/22, Programa "Ramon Llull," contractes per a la Intensificació de l'Activitat Investigadora a l'IdISBa 2020, IdISBa COVID-19/22, Programa “Ramon Llull”,.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although pulmonary embolism (PE) is a frequent complication in COVID-19, its consequences remain unknown. We performed pulmonary function tests, echocardiography and computed tomography pulmonary angiography and identified blood biomarkers in a cohort of consecutive hospitalized COVID-19 patients with pneumonia to describe and compare medium-term outcomes according to the presence of PE, as well as to explore their potential predictors. A total of 141 patients (56 with PE) were followed up during a median of 6 months. Post-COVID-19 radiological lung abnormalities (PCRLA) and impaired diffusing capacity for carbon monoxide (DLCOc) were found in 55.2% and 67.6% cases, respectively. A total of 7.3% had PE, and 6.7% presented an intermediate–high probability of pulmonary hypertension. No significant difference was found between PE and non-PE patients. Univariate analysis showed that age > 65, some clinical severity factors, surfactant protein-D, baseline C-reactive protein, and both peak red cell distribution width and Interleukin (IL)-10 were associated with DLCOc < 80%. A score for PCRLA prediction including age > 65, minimum lymphocyte count, and IL-1β concentration on admission was constructed with excellent overall performance. In conclusion, reduced DLCOc and PCRLA were common in COVID-19 patients after hospital discharge, but PE did not increase the risk. A PCRLA predictive score was developed, which needs further validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary EmbolismHumansMaleFemaleAgedMiddle AgedSARS-CoV-2Respiratory Function TestsLungBiomarkersEchocardiographyHypertension, Pulmonary

Stichwörter der Autor:innen

COVID-19SARS-CoV-2cardiopulmonary complicationsfollow-uppneumoniapulmonary embolismthrombosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Servicio de Neumología, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain.
  • Institut d'Investigació Sanitària Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
  • Servicio de Radiodiagnóstico, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain.
  • Servicio de Cardiología, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain.
  • Facultad de Medicina, Universidad de las Islas Baleares, 07122 Palma, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Alberto Alonso-Fernández

Förderung

  • IdISBa COVID-19/22, Programa "Ramon Llull," contractes per a la Intensificació de l'Activitat Investigadora a l'IdISBa 2020
  • IdISBa COVID-19/22
  • Programa “Ramon Llull”,

Zitieren

APA

Suarez-Castillejo, C., Calvo, N., Preda, L., Córdova Díaz, R., Toledo-Pons, N., Martínez, J., Pons, J., Vives-Borràs, M., Pericàs, P., Ramón, L., Iglesias, A., Cànaves-Gómez, L., Valera Felices, J. L., Morell-García, D., Núñez, B., Sauleda, J., Sala-Llinàs, E., & Alonso-Fernández, A. (2024). Cardiopulmonary Complications after Pulmonary Embolism in COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137270

Vancouver

Suarez-Castillejo C, Calvo N, Preda L, Córdova Díaz R, Toledo-Pons N, Martínez J, et al. Cardiopulmonary Complications after Pulmonary Embolism in COVID-19. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137270

BibTeX
@article{SuarezCastillejo2024,
  author = {Suarez-Castillejo, Carla and Calvo, Néstor and Preda, Luminita and Córdova Díaz, Rocío and Toledo-Pons, Nuria and Martínez, Joaquín and Pons, Jaume and Vives-Borràs, Miquel and Pericàs, Pere and Ramón, Luisa and Iglesias, Amanda and Cànaves-Gómez, Laura and Valera Felices, Jose Luis and Morell-García, Daniel and Núñez, Belén and Sauleda, Jaume and Sala-Llinàs, Ernest and Alonso-Fernández, Alberto},
  title = {Cardiopulmonary Complications after Pulmonary Embolism in COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137270}
}
Kostenlos starten →